Fennec Pharmaceuticals Files 8-K on Security Holder Votes
Ticker: FENC · Form: 8-K · Filed: Jun 25, 2024 · CIK: 1211583
| Field | Detail |
|---|---|
| Company | Fennec Pharmaceuticals Inc. (FENC) |
| Form Type | 8-K |
| Filed Date | Jun 25, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-vote, corporate-governance
Related Tickers: FENN
TL;DR
FENN shares: Company held shareholder vote on June 25th, details to follow.
AI Summary
Fennec Pharmaceuticals Inc. filed an 8-K on June 25, 2024, to report on matters submitted to a vote of its security holders. The filing does not contain specific details about the votes or resolutions presented, but it serves as an official notification of such events.
Why It Matters
This filing indicates that Fennec Pharmaceuticals held a meeting where shareholders voted on important company matters, which could impact the company's future direction or governance.
Risk Assessment
Risk Level: low — The filing is a procedural notification of a shareholder vote without immediate financial or operational impact disclosed.
Key Players & Entities
- Fennec Pharmaceuticals Inc. (company) — Registrant
- June 25, 2024 (date) — Date of earliest event reported
FAQ
What specific matters were submitted for a vote by Fennec Pharmaceuticals' security holders?
The 8-K filing does not specify the exact matters submitted for a vote, only that such matters were presented.
When did the event related to the security holder vote occur?
The earliest event reported in the filing occurred on June 25, 2024.
What is the Commission File Number for Fennec Pharmaceuticals Inc.?
The Commission File Number for Fennec Pharmaceuticals Inc. is 001-32295.
Where is Fennec Pharmaceuticals Inc. incorporated?
Fennec Pharmaceuticals Inc. is incorporated in British Columbia, Canada.
What is the business address of Fennec Pharmaceuticals Inc.?
The business address is PO Box 13628, 68 TW Alexander Drive, Research Triangle Park, NC 27709.
Filing Stats: 530 words · 2 min read · ~2 pages · Grade level 12 · Accepted 2024-06-25 16:11:57
Filing Documents
- tm2418225d1_8k.htm (8-K) — 32KB
- 0001104659-24-074748.txt ( ) — 201KB
- fencf-20240625.xsd (EX-101.SCH) — 3KB
- fencf-20240625_lab.xml (EX-101.LAB) — 33KB
- fencf-20240625_pre.xml (EX-101.PRE) — 22KB
- tm2418225d1_8k_htm.xml (XML) — 4KB
07 Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders. On June 25, 2024, Fennec Pharmaceuticals Inc. (the "Company") held an annual meeting of shareholders (the "Meeting"). The shareholders approved all proposals considered at the Meeting and approved all nominees of the Company for director, as follows: 1. The following five (5) nominees were elected to serve as directors, each to serve until the next annual meeting of shareholders of the Company or until their respective successor shall have been duly elected or duly approved: Name of Nominee Votes For Votes Withheld Broker Non-Votes Dr. Khalid Islam 10,100,238 371,270 6,091,979 Chris A. Rallis 9,688,517 782,991 6,091,979 Marco Brughera 9,801,305 670,203 6,091,979 Jodi Cook 8,991,182 1,480,326 6,091,979 Rostislav Raykov 9,859,679 611,829 6,091,979 2. The resolution to appoint Haskell & White LLP as independent public accounting firm of the Company and to authorize the Board of Directors to fix their remuneration was approved based on the following vote: Votes For 16,225,975 Votes Withheld 337,512 Votes Against 0 Broker Non-Votes 0 3. The resolution to vote on the advisory vote on executive compensation was approved based on the following vote: Votes For 9,830,484 Votes Against 346,881 Abstentions 294,143 Broker Non-Votes 6,091,979 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. FENNEC PHARMACEUTICALS INC. Date June 25, 2024 By: /s/ Rostislav Raykov Rostislav Raykov Chief Executive Officer 3